Gilead Sciences Inc. (GILD)
104.54
-0.34 (-0.32%)
At close: Apr 17, 2025, 3:59 PM
104.18
-0.35%
After-hours: Apr 17, 2025, 07:55 PM EDT
Gilead Sciences Revenue Breakdown
| Period Ending | Sep 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cell Therapy Products, Total Cell Therapy Product Sales Revenue | 970M | 960M | n/a | 973M | 937M | 896M | n/a | 796M | 736M | 548M | n/a | 444M | 438M | 351M | 16.95B | 13M | 28M | 8M | 10M | 5M | 15M | 17M | 28M | 14M | 19M |
| Cell Therapy Products, Total Cell Therapy Product Sales Revenue Growth | +1.04% | n/a | -100.00% | +3.84% | +4.58% | n/a | -100.00% | +8.15% | +34.31% | n/a | -100.00% | +1.37% | +24.79% | -97.93% | +130261.54% | -53.57% | +250.00% | -20.00% | +100.00% | -66.67% | -11.76% | -39.29% | +100.00% | -26.32% | n/a |
| Products, Other HIV Revenue | 5.07B | 4.34B | 201M | 216M | 243M | 199M | 254M | 200M | 256M | 236M | 250M | 245M | 291M | 241M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Products, Other HIV Revenue Growth | +16.84% | +2060.20% | -6.94% | -11.11% | +22.11% | -21.65% | +27.00% | -21.88% | +8.47% | -5.60% | +2.04% | -15.81% | +20.75% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Products, Total Other product sales Revenue | 201M | 224M | 4.71B | 4.68B | 4.65B | 4.2B | 4.79B | 4.5B | 4.25B | 3.72B | 4.55B | 4.2B | 3.95B | 3.67B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Products, Total Other product sales Revenue Growth | -10.27% | -95.24% | +0.56% | +0.73% | +10.65% | -12.25% | +6.36% | +5.96% | +14.11% | -18.27% | +8.51% | +6.25% | +7.69% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Trodelvy Revenue | 332M | 309M | 298M | 283M | 260M | 222M | 195M | 180M | 159M | 146M | 118M | 101M | 89M | 72M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Trodelvy Revenue Growth | +7.44% | +3.69% | +5.30% | +8.85% | +17.12% | +13.85% | +8.33% | +13.21% | +8.90% | +23.73% | +16.83% | +13.48% | +23.61% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Veklury Revenue | 692M | 555M | 719M | 636M | 256M | 573M | 1B | 925M | 445M | 1.53B | 1.36B | 1.92B | 829M | 1.46B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Veklury Revenue Growth | +24.68% | -22.81% | +13.05% | +148.44% | -55.32% | -42.70% | +8.11% | +107.87% | -71.01% | +13.12% | -29.43% | +131.97% | -43.06% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Europe Revenue | 4.31B | 4.47B | 4.87B | 4.13B | 3.81B | 4.01B | 5.31B | 6.37B | 7.53B | 5.44B | 3.61B | 3.33B | 4.61B | 4.28B |
| Europe Revenue Growth | -3.56% | -8.31% | +17.87% | +8.50% | -4.87% | -24.57% | -16.56% | -15.45% | +38.33% | +50.61% | +8.42% | -27.68% | +7.67% | n/a |
| Other International Revenue | 3.37B | 3.93B | 3.16B | 2.34B | 1.99B | 1.85B | 2.6B | 2.14B | 3.88B | 1.27B | 893.1M | 777.71M | 652.34M | 4.22B |
| Other International Revenue Growth | -14.26% | +24.15% | +35.39% | +17.26% | +7.61% | -28.82% | +21.36% | -44.70% | +206.24% | +41.75% | +14.84% | +19.22% | -84.56% | n/a |
| United States Revenue | 19.44B | 18.88B | 19.27B | 18.22B | 16.64B | 16.27B | 18.19B | 19.35B | 21.23B | 18.18B | 6.7B | 5.59B | n/a | n/a |
| United States Revenue Growth | +2.93% | -1.99% | +5.76% | +9.44% | +2.31% | -10.58% | -5.99% | -8.85% | +16.79% | +171.57% | +19.73% | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1.91B | 1.43B | 1.37B | 1.36B | 1.6B | 1.31B | 1.85B | 1.32B | 2.02B | 1.21B | 1.36B | 1.08B | 1.65B | 1.19B | 1.35B | 1.05B | 1.73B | 1.11B | 1.24B | 1.08B | 1.2B | 1.05B | 1.09B | 1.03B | 1.13B | 948M | 980M | 997M | 1.25B | 879M | 897M | 850M | 992M | 831M | 890M | 685M | 1.07B | 903M | 812M | 645M |
| Selling, General, and Administrative Revenue Growth | +33.01% | +4.67% | +0.51% | -14.72% | +21.44% | -28.88% | +40.18% | -34.70% | +66.53% | -10.61% | +25.30% | -34.36% | +38.66% | -11.92% | +28.06% | -39.02% | +56.42% | -10.73% | +15.15% | -10.63% | +14.45% | -3.93% | +6.31% | -8.93% | +19.30% | -3.27% | -1.71% | -20.37% | +42.43% | -2.01% | +5.53% | -14.31% | +19.37% | -6.63% | +29.93% | -35.74% | +18.05% | +11.21% | +25.89% | n/a |
| Research and Development Revenue | 1.64B | 1.4B | 1.35B | 1.47B | 1.45B | 1.46B | 1.41B | 1.45B | 1.55B | 1.15B | 1.1B | 3.89B | 2.03B | 1.15B | 1.13B | 1.05B | 1.58B | 1.16B | 1.3B | 1.1B | 1.9B | 4.99B | 1.16B | 1.06B | 1.95B | 939M | 1.19B | 937M | 1.15B | 789M | 864M | 931M | 1.21B | 1.14B | 1.48B | 1.26B | 757M | 743M | 818M | 696M |
| Research and Development Revenue Growth | +17.63% | +3.49% | -8.30% | +1.24% | -0.34% | +3.55% | -2.76% | -6.52% | +34.73% | +4.26% | -71.64% | +91.71% | +76.72% | +1.15% | +7.49% | -33.14% | +36.27% | -10.85% | +17.98% | -42.02% | -61.94% | +330.17% | +9.74% | -45.79% | +107.67% | -21.22% | +27.21% | -18.52% | +45.75% | -8.68% | -7.20% | -22.93% | +5.87% | -23.11% | +17.31% | +67.11% | +1.88% | -9.17% | +17.53% | n/a |